Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Trading Down 4.2% – Should You Sell?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY)’s stock price fell 4.2% during trading on Friday . The company traded as low as $8.40 and last traded at $8.40. 531 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 102,653 shares. The stock had previously closed at $8.77.

Shionogi & Co., Ltd. Unsponsored ADR Trading Down 1.7%

The firm has a market capitalization of $14.67 billion, a P/E ratio of 13.47, a P/E/G ratio of 2.04 and a beta of 0.20. The company has a current ratio of 6.44, a quick ratio of 5.74 and a debt-to-equity ratio of 0.01. The company’s fifty day moving average is $8.41 and its 200-day moving average is $8.57.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last released its earnings results on Monday, October 27th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.02. The firm had revenue of $740.85 million during the quarter, compared to analyst estimates of $742.35 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 39.53% and a return on equity of 11.90%. As a group, sell-side analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 earnings per share for the current fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.